Tomoki Sakaue - Publications

Visceral technetium-99 m-labeled pyrophosphate uptake in patients with wild-type transthyretin cardiac amyloidosis.

Journal: Annals of nuclear medicine

Published: December 04, 2025

Differences in Coronary Microvascular Spasms Induced by Acetylcholine and Ergonovine.

Journal: Internal medicine (Tokyo, Japan)

Published: November 26, 2025

Tracking a patient with no technetium-99m-pyrophosphate myocardial uptake at surgical valve replacement for aortic stenosis.

Journal: Journal of geriatric cardiology : JGC

Published: October 27, 2025

Amyloid myopathy in the internal oblique muscle of patients with wild-type transthyretin cardiac amyloidosis.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: October 11, 2025

Technetium-99m-labeled pyrophosphate uptake in the rectum of a patient with wild-type transthyretin cardiac amyloidosis.

Journal: Radiology case reports

Published: September 16, 2025

What are the Safest and Easiest Extra-Cardiac Biopsy Sites for the Diagnosis of Wild-Type Transthyretin Cardiac Amyloidosis? Confirmation of the Diagnosis by Biopsy of the Pectoralis Muscle During Pacemaker Insertion.

Journal: European journal of case reports in internal medicine

Published: August 21, 2025

Another example of Aslanger' s sign.

Journal: Journal of geriatric cardiology : JGC

Published: May 12, 2025

Understanding of therapeutic efficacy of coronary intervention by echocardiography in a patient with acute coronary syndrome.

Journal: Journal of echocardiography

Published: September 01, 2024

Lack of Class I Vasoreactivity Testing for Diagnosing Patients With Coronary Artery Spasm.

Journal: Clinical cardiology

Published: July 27, 2024

Downsloping TP Segment in the Precordial Leads on a Standard 12-lead Electrocardiogram: Suspected Cardiac Impulse-tapping Artifact.

Journal: Internal medicine (Tokyo, Japan)

Published: May 29, 2024

Safety and Usefulness of Intracoronary Acetylcholine 200 μg Into the Left Coronary Artery as Vasoreactivity Testing: Comparisons With Intracoronary Acetylcholine Maximum 100 μg.

Journal: Clinical cardiology

Published: April 25, 2024

"Loss of Bone Signal" on 99m Tc-Labeled Pyrophosphate Scintigraphy in a Patient With Wild-Type Transthyretin Amyloidosis.

Journal: Clinical nuclear medicine

Published: April 23, 2024